Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled study
Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled study
Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled study
Status
Status :
Completed
Type of study
Phase IV
Min. Age
40
Years old
Max. Age
75
Years old
Gender
All
Therapeutic area :
Rhumatology
Disease :
Osteoarthritis
Study medication :
Structum
Phase :
Phase IV
Start Date :
17 November 2005
End date :
07 November 2006
Study ID :
L00023 GE 404
EudraCT/CTIS number :
2005-000508-15
Send by email